Introduced September 10, 2025 by Richard Hudson · Last progress September 10, 2025
The bill standardizes and makes Medicare lab-payment setting more transparent and stable—helping patients and labs avoid payment shocks—but concentrates data authority and compliance burdens, which could raise costs, slow rate-setting, and increase privacy and market-power risks.
Patients who need clinical lab testing and the hospitals/clinical labs that provide those tests will face fewer sudden disruptions because a default inflation-based payment rule maintains payments if data access or validation is delayed.
Medicare reimbursement for clinical lab tests will be more consistent and standardized because payment rates will be set using a certified national claims database.
Clinical laboratories and payors gain clearer, public explanations of how Medicare sets payment rates, enabling labs to verify calculations and challenge errors.
Payors, data providers, and ultimately taxpayers or consumers could face higher costs because new reporting, validation, and participation requirements increase administrative burden.
Concentrating authority in a single certified national nonprofit database risks creating market power and switching or participation costs for database operators and payors.
Heavy reliance on private-payor claims and tighter validation could slow rate-setting during contract or data disputes, creating temporary uncertainty in Medicare lab payments despite the default rule.
Based on analysis of 2 sections of legislative text.
Requires Medicare to use private‑payor data from a qualifying independent comprehensive claims database run by an independent nonprofit to set payment rates for widely available non‑ADLT lab tests, phased 2027–2028.
Changes how Medicare gathers private-payor data used to set payment rates for widely available non‑Advanced diagnostic laboratory tests by requiring that, starting in phases, the Secretary rely on data from a qualifying comprehensive claims database run by an independent national nonprofit (with which HHS must contract). It revises definitions and timing rules for data collection and directs the Secretary to identify and contract with a qualifying database entity as soon as practicable.